No Data
Marvell Technology Soars on NVIDIA CEO's Endorsement, Joins Relmada Therapeutics and Other Big Stocks Moving Higher in Wednesday's Pre-Market Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Relmada Therapeutics Increases Authorized Shares After Shareholder Vote
Express News | Relmada Therapeutics - Increases Authorized Common Stock to 200 Mln Shares From 150 Mln - SEC Filing
Relmada Therapeutics to Present at the Jefferies Global Healthcare Conference
Relmada Therapeutics Charts Ambitious NDV-01 Phase 3 Path
152498972 : I chickened out early lost out